BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 17510541)

  • 1. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.
    Zech CJ; Herrmann KA; Reiser MF; Schoenberg SO
    Magn Reson Med Sci; 2007; 6(1):43-52. PubMed ID: 17510541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast agent Gd-EOB-DTPA (EOB·Primovist®) for low-field magnetic resonance imaging of canine focal liver lesions.
    Yonetomi D; Kadosawa T; Miyoshi K; Nakao Y; Homma E; Hanazono K; Yamada E; Nakamura K; Ijiri A; Minegishi N; Maetani S; Hirayama K; Taniyama H; Nakade T
    Vet Radiol Ultrasound; 2012; 53(4):371-80. PubMed ID: 22548505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging.
    Reimer P; Rummeny EJ; Daldrup HE; Hesse T; Balzer T; Tombach B; Peters PE
    Eur Radiol; 1997; 7(2):275-80. PubMed ID: 9038130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
    Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
    Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
    Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
    Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic MR imaging of liver metastases with Gd-EOB-DTPA.
    Stern W; Schick F; Kopp AF; Reimer P; Shamsi K; Claussen CD; Laniado M
    Acta Radiol; 2000 May; 41(3):255-62. PubMed ID: 10866081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions.
    Haimerl M; Wächtler M; Platzek I; Müller-Wille R; Niessen C; Hoffstetter P; Schreyer AG; Stroszczynski C; Wiggermann P
    BMC Med Imaging; 2013 Dec; 13():41. PubMed ID: 24289722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.
    Zech CJ; Grazioli L; Breuer J; Reiser MF; Schoenberg SO
    Invest Radiol; 2008 Jul; 43(7):504-11. PubMed ID: 18580333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primovist, Eovist: what to expect?
    Van Beers BE; Pastor CM; Hussain HK
    J Hepatol; 2012 Aug; 57(2):421-9. PubMed ID: 22504332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
    Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM
    Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid.
    Lin CY; Chang WC; Chou CT; Chen RC
    J Chin Med Assoc; 2015 Nov; 78(11):666-72. PubMed ID: 26341453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MR imaging of liver metastasis using Gd-EOB-DTPA].
    Kuwatsuru R
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1234-41. PubMed ID: 19692760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy.
    Sciarra A; Schmidt S; Pellegrinelli A; Maggioni M; Dondossola D; Pasquier J; Cigala C; Tosi D; Halkic N; Bulfamante G; Viale G; Bosari S; Balabaud C; Bioulac-Sage P; Sempoux C
    Liver Int; 2019 Jan; 39(1):158-167. PubMed ID: 30218633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
    Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
    Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
    Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
    J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.
    Wang YC; Chou CT; Lin CP; Chen YL; Chen YF; Chen RC
    PLoS One; 2017; 12(3):e0174594. PubMed ID: 28355258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
    Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA
    Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA.
    Saito S; Obata A; Kashiwagi Y; Abe K; Murase K
    Invest Radiol; 2013 Jul; 48(7):548-53. PubMed ID: 23442774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of incidental liver lesions: comparison of multidetector CT versus Gd-EOB-DTPA-enhanced MR imaging.
    Chung YE; Kim MJ; Kim YE; Park MS; Choi JY; Kim KW
    PLoS One; 2013; 8(6):e66141. PubMed ID: 23776623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.